Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01JPL
|
||||
Former ID |
DNCL003819
|
||||
Drug Name |
VEGFR3 Monoclonal Antibody
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [549713] | ||
Company |
Lilly
|
||||
Target and Pathway | |||||
Target(s) | Vascular endothelial growth factor receptor 3 | Target Info | Modulator | [543500] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | VEGF and VEGFR signaling network | ||||
VEGFR3 signaling in lymphatic endothelium | |||||
WikiPathways | Signaling by VEGF | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.